Adenocarcinoma of the Rectum Terminated Phase 3 Trials for Fluorouracil (DB00544)

IndicationStatusPhase
DBCOND0028688 (Adenocarcinoma of the Rectum)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00070122Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal CancerTreatment
NCT00303628Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal CancerTreatment